Moderator:
Jennifer Donkin, RN, DNP, CPNP, CFNP
Nurse Practitioner, Children's Hospital of Los Angeles

 

Speakers:

Amanda Greene, RN, MSN
Hemophilia Pediatric Lead Nurse Coordinator
Comprehensive Bleeding Disorders Center of Emory University
and Children’s Healthcare of Atlanta

Kimber Blackwell, MPAS, PA-C
Physician Assistant, Indiana Hemophilia and Thrombosis Center, Indianapolis, IN

Mary Lesh, RN, MS, CPNP
Nurse Practitioner, UCSF Benioff Children's Hospital, San Francisco, CA

Penny Kumpf, BSN, RN-BC
von Willebrand Outreach Nurse, Hemophilia of Georgia

 

After completing this activity, the participant should be better able to:

  • Review the pathophysiology of VWD.
  • Discuss the inheritance of VWD.
  • Identify the clinical manifestations of VWD.
  • Discuss 2 nursing interventions informed by the 2021 VWD guidelines applicable to care across the lifespan.
  • Identify 3 key (ASH/ISTH/WFH/NBDF) guideline recommendations in the treatment of VWD and discuss implementation and applications for HTC nursing practice.
  • Explain the mechanism of action and dosing recommendations for antifibrinolytic therapeutics in the management of VWD.